SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-052147
Filing Date
2017-09-08
Accepted
2017-09-08 18:38:46
Documents
2
Period of Report
2017-09-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1539
2 POA DOCUMENT poa.txt EX-24.3_743530 4500
  Complete submission text file 0001209191-17-052147.txt   7513
Mailing Address C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Carter Eric G (Reporting) CIK: 0001387660 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 171077576

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)